KIT-302 is a combination drug comprised of two drugs that are already FDA-approved, amlodipine besylate
for the reduction of high blood pressure and celecoxib for reduction of pain caused by osteoarthritis.
Contract awarded for code igss 10,352 amlodipine besylate
, bisoprolol fumarate tablet 5 mg / 10 mg
This report discusses marketed products including Prestalia (perindopril arginine + amlodipine besylate
), Azilva (azilsartan medoxomil), Amlodipine besylate
, Telmisartan, Aliskiren, Olmesartan medoxomil, Valsartan, Losartan and Exforge (amlodipine + valsartan).
On January 3, 2011, Par Pharmaceutical successfully launched all strengths of amlodipine besylate
and benazepril hydrochloride capsules, the generic version of Novartis' Lotrel [R] .
The combination of olmesartan medoxomil and amlodipine besylate
in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
Court of Appeals for the Federal Circuit in March invalidated the patent on Norvasc's key ingredient, amlodipine besylate
The ASCOT-BPLA trial has specifically demonstrated that a regimen starting with amlodipine besylate
is better at reducing total cardiovascular events and procedures, fatal and non-fatal stroke, and the risk of new-onset diabetes.
4,879,303) covering amlodipine besylate
is valid, enforceable and would be
Food and Drug Administration (FDA) for a fixed dose combination of two antihypertensives, the calcium channel blocker (CCB) amlodipine besylate
(currently marketed by Pfizer as Norvasc) and the angiotensin receptor blocker (ARB) olmesartan medoxomil, or Benicar.
The patient's blood pressure was then controlled with amlodipine besylate
, a calcium channel blocker.
Triple therapy with Olmesartan medoxomil, amlodipine besylate
, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-bline, 12-week, parallel-group study.
Court of Appeals for the Federal Circuit in Washington held invalid the patent on the drug's key ingredient, amlodipine besylate
, overturning a January 2006 ruling by District Judge James M.